Filtered By:
Condition: Heart Attack

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 20589 results found since Jan 2013.

Blood Pressure-Lowering Treatment With Candesartan in Patients With Acute Hemorrhagic Stroke Brief Reports
Conclusions— There was no evidence that blood pressure–lowering treatment with candesartan is beneficial during the first week of hemorrhagic stroke. Instead, there were signs that such treatment may be harmful, but this needs to be verified in larger studies. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00120003.
Source: Stroke - October 27, 2014 Category: Neurology Authors: Jusufovic, M., Sandset, E. C., Bath, P. M. W., Berge, E., on behalf of the Scandinavian Candesartan Acute Stroke Trial Study Group Tags: Cerebrovascular disease/stroke, Acute Cerebral Hemorrhage, Other Stroke Treatment - Medical Brief Reports Source Type: research

Prevalence of physical activity and sedentary behavior among stroke survivors in the United States.
Conclusion: Findings from this study provide a basis for future work seeking to measure the impact of physical activity on the secondary prevention of stroke by characterizing the prevalence of physical activity and sedentary behavior among stroke survivors in the United States. PMID: 24985392 [PubMed - in process]
Source: Topics in Stroke Rehabilitation - May 1, 2014 Category: Neurology Authors: Butler EN, Evenson KR Tags: Top Stroke Rehabil Source Type: research

One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010 Clinical Sciences
Conclusions—The risk of recurrent ischemic stroke decreased from 1998 to 2010. Well-known risk factors for stroke were associated with a higher risk of ischemic stroke recurrence; whereas, secondary preventive medication was associated with a reduced risk, emphasizing the importance of secondary preventive treatment.
Source: Stroke - July 24, 2017 Category: Neurology Authors: Lisa Bergstrom, Anna–Lotta Irewall, Lars Soderstrom, Joachim Ogren, Katarina Laurell, Thomas Mooe Tags: Epidemiology, Risk Factors, Secondary Prevention, Quality and Outcomes, Ischemic Stroke Original Contributions Source Type: research

Physical activity after ischemic stroke and its association with adverse outcomes: A nationwide population-based cohort study.
CONCLUSIONS: Achieving a sufficient PA level after ischemic stroke appears to significantly reduce major adverse events. Further effort is needed to promote the PA level after ischemic stroke. PMID: 32726190 [PubMed - as supplied by publisher]
Source: Topics in Stroke Rehabilitation - July 28, 2020 Category: Neurology Authors: Kang SM, Kim SH, Han KD, Paik NJ, Kim WS Tags: Top Stroke Rehabil Source Type: research

Long-Term Risk and Predictors of Recurrent Stroke Beyond the Acute Phase Brief Reports
Conclusions— Despite declining recurrence rates in this relatively young stroke population, almost one third are either dead or have experienced a second stroke in 5 years.
Source: Stroke - May 27, 2014 Category: Neurology Authors: Pennlert, J., Eriksson, M., Carlberg, B., Wiklund, P.-G. Tags: Risk Factors for Stroke, Epidemiology Brief Reports Source Type: research

Embolic Strokes of Undetermined Source in the Athens Stroke Registry: An Outcome Analysis Clinical Sciences
Conclusions— Long-term mortality risk in ESUS is lower compared with cardioembolic strokes, despite similar rates of recurrence and composite cardiovascular end point. Recurrent stroke risk is higher in ESUS than in noncardioembolic strokes.
Source: Stroke - July 27, 2015 Category: Neurology Authors: Ntaios, G., Papavasileiou, V., Milionis, H., Makaritsis, K., Vemmou, A., Koroboki, E., Manios, E., Spengos, K., Michel, P., Vemmos, K. Tags: Embolic stroke Clinical Sciences Source Type: research

Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics Clinical Sciences
Conclusions— In the prehospital setting, copeptin is neither appropriate to discriminate between stroke and stroke mimic patients nor between vascular and nonvascular patients. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01382862. The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients study (PHANTOM-S) was registered (NCT01382862). This sub-study was observational and not registered separately, therefore.
Source: Stroke - August 24, 2015 Category: Neurology Authors: Wendt, M., Ebinger, M., Kunz, A., Rozanski, M., Waldschmidt, C., Weber, J. E., Winter, B., Koch, P. M., Nolte, C. H., Hertel, S., Ziera, T., Audebert, H. J., for the STEMO Consortium Tags: Cerebrovascular disease/stroke, Clinical Studies, Other diagnostic testing, Acute Cerebral Infarction Clinical Sciences Source Type: research

Long-Term Risk of Stroke in Myocardial Infarction Survivors: Thirty-Year Population-Based Cohort Study Clinical Sciences
Conclusions— MI was a risk factor for all stroke subtypes during the first year of follow-up, but only for ischemic stroke thereafter.
Source: Stroke - June 26, 2016 Category: Neurology Authors: Sundboll, J., Horvath-Puho, E., Schmidt, M., Pedersen, L., Henderson, V. W., Botker, H. E., Sorensen, H. T. Tags: Cardiovascular Disease, Epidemiology, Myocardial Infarction, Intracranial Hemorrhage, Ischemic Stroke Clinical Sciences Source Type: research

Predictors of Thrombolysis Administration in Mild Stroke Clinical Sciences
Conclusions—Mild acutely presenting stroke patients are more likely to receive thrombolysis if they are young, white, or Hispanic and arrive early to the hospital with more severe neurological presentation. Identification of predictors of thrombolysis is important in design of future studies to assess the use of thrombolysis for mild stroke.
Source: Stroke - February 26, 2018 Category: Neurology Authors: Negar Asdaghi, Kefeng Wang, Maria A. Ciliberti-Vargas, Carolina Marinovic Gutierrez, Sebastian Koch, Hannah Gardener, Chuanhui Dong, David Z. Rose, Enid J. Garcia, W. Scott Burgin, Juan Carlos Zevallos, Tatjana Rundek, Ralph L. Sacco, Jose G. Romano Tags: Cerebrovascular Disease/Stroke, Ischemic Stroke, Transient Ischemic Attack (TIA) Original Contributions Source Type: research

Adiposity, Adipokines, and Risk of Incident Stroke in Older Men Original Contributions
Conclusions— Conventional adiposity measures were not associated with increased stroke risk in older men. However, leptin (a good marker of percent fat mass), but not adiponectin, predicted stroke, suggesting a link between fat mass and stroke risk.
Source: Stroke - December 24, 2012 Category: Neurology Authors: Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., Sattar, N. Tags: Acute Cerebral Infarction, Risk Factors for Stroke, Epidemiology Original Contributions Source Type: research

Pioglitazone for Secondary Stroke Prevention Clinical Sciences
Conclusions—Pioglitazone reduces recurrent stroke and major vascular events in ischemic stroke patients with insulin resistance, prediabetes, and diabetes mellitus.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Meng Lee, Jeffrey L. Saver, Hung-Wei Liao, Chun-Hsien Lin, Bruce Ovbiagele Tags: Cardiovascular Disease, Diabetes, Type 2, Secondary Prevention, Meta Analysis, Cerebrovascular Disease/Stroke Original Contributions Source Type: research

Feasibility and Diagnostic Value of Cardiovascular Magnetic Resonance Imaging After Acute Ischemic Stroke of Undetermined Origin Clinical Sciences
Conclusions—Our study demonstrated that cvMRI was feasible in the vast majority of included patients with acute ischemic stroke. The diagnostic information of cvMRI seems to be complementary to TEE but is not replacing echocardiography after acute ischemic stroke.Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01917955.
Source: Stroke - April 24, 2017 Category: Neurology Authors: Karl Georg Haeusler, Christian Wollboldt, Laura zu Bentheim, Juliane Herm, Sebastian Jager, Claudia Kunze, Holger–Carsten Eberle, Claudia Christina Deluigi, Oliver Bruder, Carolin Malsch, Peter U. Heuschmann, Matthias Endres, Heinrich J. Audebert, A Tags: Secondary Prevention, Echocardiography, Magnetic Resonance Imaging (MRI), Ischemic Stroke Original Contributions Source Type: research

C-Reactive Protein as a Prognostic Marker After Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study Clinical Sciences
Conclusions— Among recent lacunar stroke patients, hsCRP levels predict the risk of recurrent strokes and other vascular events. hsCRP did not predict the response to dual antiplatelets. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059306.
Source: Stroke - February 24, 2014 Category: Neurology Authors: Elkind, M. S. V., Luna, J. M., McClure, L. A., Zhang, Y., Coffey, C. S., Roldan, A., Del Brutto, O. H., Pretell, E. J., Pettigrew, L. C., Meyer, B. C., Tapia, J., White, C., Benavente, O. R., on behalf of the LIMITS Investigators, The LIMITS Investigators Tags: Cerebrovascular disease/stroke, Cerebral Lacunes, Epidemiology Clinical Sciences Source Type: research

Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study Brief Reports
Conclusions— Increased cIMT and presence of carotid plaque are associated with increased risk of ischemic stroke in individuals with AF. Furthermore, they may improve risk prediction of stroke, over and above the CHA2DS2-VASc score.
Source: Stroke - May 22, 2016 Category: Neurology Authors: Bekwelem, W., Jensen, P. N., Norby, F. L., Soliman, E. Z., Agarwal, S. K., Lip, G. Y. H., Pan, W., Folsom, A. R., Longstreth, W. T., Alonso, A., Heckbert, S. R., Chen, L. Y. Tags: Atrial Fibrillation, Risk Factors, Ischemic Stroke, Atherosclerosis Brief Reports Source Type: research

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial Clinical Sciences
Conclusions— In patients with systolic HF and sinus rhythm, LVEF is inversely associated with death and its components, whereas an association with stroke exists for very low LVEF values. An interaction with warfarin treatment on stroke risk may exist. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00041938.
Source: Stroke - July 24, 2016 Category: Neurology Authors: Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., Sacco, R. L., Pullicino, P. M., Freudenberger, R. S., Teerlink, J. R., Graham, S., Lip, G. Y. H., Levin, B., Mohr, J. P., Buchsbaum, R., Estol, C. J., Lok, D. J., Ponikowski, P. Tags: Heart Failure, Echocardiography, Anticoagulants, Ischemic Stroke Clinical Sciences Source Type: research